{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:22:30Z","timestamp":1790256150958,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T00:00:00Z","timestamp":1246924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1007\/s11095-009-9934-y","type":"journal-article","created":{"date-parts":[[2009,7,6]],"date-time":"2009-07-06T17:17:32Z","timestamp":1246900652000},"page":"2194-2201","source":"Crossref","is-referenced-by-count":36,"title":["An Ex Vivo Toe Model Used to Assess Applicators for the Iontophoretic Ungual Delivery of Terbinafine"],"prefix":"10.1007","volume":"26","author":[{"given":"Anroop B.","family":"Nair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn P.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Etheredge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Barsness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Friden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Narasimha Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"9934_CR1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0926-9959(94)00073-9","volume":"4","author":"I Effendy","year":"1995","unstructured":"Effendy I. Therapeutic strategies in onychomycosis. J Eur Acad Dermatol Venereol. 1995;4:S3\u2013S10.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9934_CR2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14728214.12.3.345","volume":"12","author":"GE Pierard","year":"2007","unstructured":"Pierard GE, Arrese JE, Quatresooz P, Pierard-Franchimont C. Emerging therapeutics agents for onychomycosis. Expert Opin Emerging Drugs. 2007;12:345\u2013353.","journal-title":"Expert Opin Emerging Drugs"},{"key":"9934_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","volume":"207","author":"JE Arrese","year":"2003","unstructured":"Arrese JE, Pierard GE. Treatment failures and relapses in onychomycosis; a stubborn clinical problem. Dermatol. 2003;207:255\u2013260.","journal-title":"Dermatol"},{"key":"9934_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","volume":"19","author":"R Baran","year":"2005","unstructured":"Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol. 2005;19:21\u201329.","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"9934_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","volume":"20","author":"JJ Finch","year":"2007","unstructured":"Finch JJ, Warshaw EM. Toenail onychomycosis: current and future treatment options. Dermatol Ther. 2007;20:31\u201346.","journal-title":"Dermatol Ther"},{"key":"9934_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","volume":"236","author":"S Murdan","year":"2002","unstructured":"Murdan S. Drug delivery to the nail following topical application. Int J Pharm. 2002;236:1\u201326.","journal-title":"Int J Pharm"},{"key":"9934_CR7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7547\/87507315-93-2-136","volume":"93","author":"MA Bodman","year":"2003","unstructured":"Bodman MA, Feder L, Nace AM. Topical treatments for onychomycosis. J Am Podiatr Med Assoc. 2003;93:136\u2013141.","journal-title":"J Am Podiatr Med Assoc"},{"key":"9934_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jps.10003","volume":"91","author":"X Hui","year":"2002","unstructured":"Hui X, Shainhouse Z, Tanojo H, Anigbogu A, Markus GE, Maibach HI, et al. Enhanced human nail drug delivery: nail inner drug content assayed by new unique method. J Pharm Sci. 2002;91:189\u2013195.","journal-title":"J Pharm Sci"},{"key":"9934_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0928-0987(97)00270-4","volume":"5","author":"EJ Hoogdalem Van","year":"1997","unstructured":"Van Hoogdalem EJ, Van den Hoven WE, Terpstra IJ, Van Zijtveld J, Verschoor JSC, Visser JN. Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine. Eur J Pharm Sci. 1997;5:119\u2013127.","journal-title":"Eur J Pharm Sci"},{"key":"9934_CR10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1248\/cpb.46.1797","volume":"46","author":"Y Kobayashi","year":"1998","unstructured":"Kobayashi Y, Miyamoto M, Sugibayashi K, Morimoto Y. Enhancing effect of Nacetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate. Chem Pharm Bull. 1998;46:1797\u20131802.","journal-title":"Chem Pharm Bull"},{"key":"9934_CR11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jps.10058","volume":"91","author":"GG Malhotra","year":"2002","unstructured":"Malhotra GG, Zatz JL. Investigation of nail permeation enhancement by chemical modification using water as a probe. J Pharm Sci. 2002;91:312\u2013323.","journal-title":"J Pharm Sci"},{"key":"9934_CR12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jps.10291","volume":"92","author":"X Hui","year":"2003","unstructured":"Hui X, Chan TCK, Barbadillo S, Lee C, Maibach HI, Wester RC. Enhanced econazole penetration into human nail by 2-n-nonyl-1, 3-dioxolane. J Pharm Sci. 2003;92:142\u2013148.","journal-title":"J Pharm Sci"},{"key":"9934_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.01.027","volume":"357","author":"J Hao","year":"2008","unstructured":"Hao J, Smith KA, Li SK. Chemical method to enhance transungual transport and iontophoresis efficiency. Int J Pharm. 2008;357:61\u201369.","journal-title":"Int J Pharm"},{"key":"9934_CR14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17425240802497218","volume":"5","author":"S Murdan","year":"2008","unstructured":"Murdan S. Enhancing the nail permeability of topically applied drugs. Expert Opin Drug Deliv. 2008;5:1267\u20131282.","journal-title":"Expert Opin Drug Deliv"},{"key":"9934_CR15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejps.2003.11.008","volume":"21","author":"Y Kobayashi","year":"2004","unstructured":"Kobayashi Y, Komatsu T, Sumi M, Numajiri S, Miyamoto M, Kobayashi D, et al. In vitro permeation of several drugs through the human nail plate: relationship between physicochemical properties and nail permeability of drugs. Eur J Pharm Sci. 2004;21:471\u2013477.","journal-title":"Eur J Pharm Sci"},{"key":"9934_CR16","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/jps.21555","volume":"98","author":"AB Nair","year":"2009","unstructured":"Nair AB, Vaka SRK, Sammeta SM, Kim HD, Friden PM, Bireswar C, et al. Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci. 2009;98:1788\u20131796.","journal-title":"J Pharm Sci"},{"key":"9934_CR17","doi-asserted-by":"crossref","unstructured":"Nair AB, Kim HD, Chakraborty B, Singh J, Zaman M, Gupta A, et al. Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis (In press). J Pharm Sci. 2009b.","DOI":"10.1002\/jps.21711"},{"key":"9934_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.1990.tb01453.x","volume":"123","author":"PJ Dykes","year":"1990","unstructured":"Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol. 1990;123:481\u2013486.","journal-title":"Br J Dermatol"},{"key":"9934_CR19","first-page":"633","volume-title":"Percutaneous Absorption","author":"P Singh","year":"1999","unstructured":"Singh P, Liu P, Dinh SM. Facilitated transdermal delivery by iontophoresis. In: Bronaugh RL, Maibach HI, editors. Percutaneous Absorption. New York: Marcel Dekker; 1999. p. 633\u2013657."},{"key":"9934_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","volume":"73","author":"J Faergemann","year":"1993","unstructured":"Faergemann J, Zehender H, Denouel J, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair, and nails during and after 250\u00a0mg terbinafine orally once per day for four weeks. Acta Derm Venereol. 1993;73:305\u2013309.","journal-title":"Acta Derm Venereol"},{"key":"9934_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.1994.tb06084.x","volume":"130","author":"YM Clayton","year":"1994","unstructured":"Clayton YM. Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses. Br J Dermatol. 1994;130:7\u20138.","journal-title":"Br J Dermatol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-009-9934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-009-9934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-009-9934-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T02:04:42Z","timestamp":1710468282000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-009-9934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,7]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["9934"],"URL":"https:\/\/doi.org\/10.1007\/s11095-009-9934-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,7]]}}}